Nilkanth Health Chem India Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 31-10-2024
- Paid Up Capital ₹ 2.49 Cr
as on 31-10-2024
- Company Age 4 Year, 17 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.72 Cr
as on 31-10-2024
- Satisfied Charges ₹ 11.18 Cr
as on 31-10-2024
- Revenue -25.37%
(FY 2023)
- Profit 7.86%
(FY 2023)
- Ebitda 83.35%
(FY 2023)
- Net Worth 6.84%
(FY 2023)
- Total Assets -22.17%
(FY 2023)
About Nilkanth Health Chem India
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.49 Cr.
The company currently has active open charges totaling ₹6.72 Cr. The company has closed loans amounting to ₹11.18 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kirti Desai and Pareshbhai Dobaria serve as directors at the Company.
- CIN/LLPIN
U24230GJ2020PTC119198
- Company No.
119198
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Bharuch, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nilkanth Health Chem India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kirti Desai  | Director | 30-Dec-2020 | Current |
| Pareshbhai Dobaria | Director | 30-Dec-2020 | Current |
Financial Performance of Nilkanth Health Chem India.
Nilkanth Health Chem India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 25.37% decrease. The company also saw a slight improvement in profitability, with a 7.86% increase in profit. The company's net worth moved up by a moderate rise of 6.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nilkanth Health Chem India?
Unlock access to Nilkanth Health Chem India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 16 Oct 2023 | ₹6.72 Cr | Open |
Others Creation Date: 23 Jun 2022 | ₹5.76 M | Satisfied |
Others Creation Date: 23 Jun 2022 | ₹4.00 M | Satisfied |
How Many Employees Work at Nilkanth Health Chem India?
Nilkanth Health Chem India has a workforce of 8 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nilkanth Health Chem India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nilkanth Health Chem India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
